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Aims Cardiomyocyte swelling occurs in multiple pathological situations and has been associated with contractile dysfunction,
cell death, and enhanced propensity to arrhythmias. We investigate whether hypotonic swelling promotes nitric oxide
(NO) release in cardiomyocytes, and whether it impacts on swelling-induced contractile dysfunction.
Methods
and results
Superfusing rat cardiomyocytes with a hypotonic solution (HS; 217 mOsm), increased cell volume, reduced myocyte
contraction and Ca2+ transient, and increased NO-sensitive 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate
(DAF-FM) fluorescence. When cells were exposed to HS + 2.5 mM of the NO synthase inhibitor L-NAME, cell swelling
occurred in the absence of NO release. Swelling-induced NO release was also prevented by the nitric oxide synthase 1
(NOS1) inhibitor, nitroguanidine, and significantly reduced in NOS1 knockout mice. Additionally, colchicine (inhibitor of
microtubule polymerization) prevented the increase in DAF-FM fluorescence induced by HS, indicating that microtubule
integrity is necessary for swelling-induced NO release. The swelling-induced negative inotropic effect was exacerbated in
the presence of either L-NAME, nitroguandine, the guanylate cyclase inhibitor, ODQ, or the PKG inhibitor, KT5823, sug-
gesting that NOS1-derived NO provides contractile support via a cGMP/PKG-dependent mechanism. Indeed, ODQ
reduced Ca2+ wave velocity and both ODQ and KT5823 reduced the HS-induced increment in ryanodine receptor
(RyR2, Ser2808) phosphorylation, suggesting that in this context, cGMP/PKG may contribute to preserve contractile
function by enhancing sarcoplasmic reticulum Ca2+ release.
Conclusions Our findings suggest a novel mechanism for NO release in cardiomyocytes with putative pathophysiological relevance
determined, at least in part, by its capability to reduce the extent of contractile dysfunction associated with hypotonic
swelling.
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1. Introduction
Tissue osmolarity is tightly regulated under physiological conditions.1
However, under diverse pathological situations, cells undergo hypoton-
ic swelling2 –4 that dilutes intracellular components and deforms cellular
membranes and the underlying cytoskeleton. This results in changes in
the activity of signalling molecules and ion channels leading to alterations
in cellular function. In the heart, cell swelling occurs in diabetic or septic
shock andelective cardioplegia, and is particularly important in thecontext
of ischaemia and reperfusion (I/R) where it results in structural, ionic, and
electrical remodelling that have been shown to contribute to contractile
dysfunction, cell death, and enhanced propensity for arrhythmias.4
Nitric oxide (NO), synthesized by the nitric oxide synthase (NOS),
has been defined as a second messenger and a regulator of cardiac exci-
tation and contraction coupling (ECC).5
Cardiomyocyte axial stretch has been shown to promote NO
release,6 and recent evidencehasemergedshowing thathypotonic swel-
ling can promote NO release in endothelial cells and in outer hair cells of
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the cochlea.7,8 However, whether hypotonic swelling can promote NO
release in cardiac ventricular myocytes has not been established. Thus,
the present study was designed to examine whether cardiomyocyte
hypotonic swelling is associated with NO release and if so, to determine
its functional implications on the swelling-induced negative inotropic
response.
Using an NO-sensitive fluorescent dye, we show for the first time
that hypotonic swelling-induced cytoskeleton deformation leads to
NOS1-dependent NO release in cardiomyocytes. This NO, through a
cGMP/PKG-dependent mechanism, provides inotropic support that
could reduce the impact of hypotonic swelling-induced contractile
dysfunction.
2. Methods
All experiments were performed in accordance with the Guide for the Care
and Use of Laboratory Animals (NIH Publication No. 85-23, revised 1996)
and approved by the Institutional Animal Care and Use Committee of La
Plata University.
2.1 Myocyte isolation
Male Wistar rats (200–300 g) were anaesthetised by an intraperitoneal
injection of sodium pentobarbitone (35 mg/kg body weight) and hearts
were excised when plane three of phase III of anaesthesia was reached.
Plane three of phase III of anaesthesia was verified by the presence of slow
deep diaphragmatic breathing, loss of the corneal reflex, and the absence
of tongue retraction.
Cardiomyocytes were isolated by collagenase-based enzymatic digestion
using a previously described technique.9
Using a similar protocol, myocytes were isolated from 3-month-old
C57BL/6 (WT, Jackson Laboratories, Bar Harbor, ME, USA) and transgenic
mice with homozygous deletions for NOS1 bred on a C57BL/6 background
(NOS1KO, Jackson Laboratories).
2.2 Experimental protocol
Myocytes were field stimulated by external platinum electrodes at 0.5 Hz
and superfused (1 mL/min at room temperature) with isotonic solution
(IS, 309 mOsm) during 5 min and then exposed to hypotonic solution
(HS, 217 mOsm). For control experiments, cardiomyocytes were kept in
IS throughout the experiment. These HEPES-buffered solutions were pre-
pared as previously described by others.10 In brief: HS (in mmol/L): NaCl
91, KCl 5.3, MgCl2 0.5, CaCl2 1, glucose 10, and HEPES 10, titrated to
pH 7.4; IS: HS + mannitol 91.5 mM.
2.3 Measurement of intracellular NO and cell
width in cardiomyocytes
Cardiomyocytes were loaded with 5 mM 4-amino-5-methylamino-2′,7′-
difluorofluorescein diacetate (DAF-FM) diacetate (Molecular Probes) for
30 min, and imaged by epifluorescence on a Zeiss 410 inverted confocal
microscope (LSM Tech, Wellsville, PA, USA). Excitation at 488 nm was pro-
vided byanargon laser andemission wascollected in a rangeof 510–530 nm.
Fluorescence was acquired for 2.5 s at 5 min intervals over the duration of
25 min. To minimize photobleaching, the lowest possible laser intensity
was used. In parallel, we acquired brightfield images to measure cell width
which was used as an estimation of the degree of cell swelling.10
2.4 Cell membrane and T-tubular system
imaging
After 20 min treatment with IS or HS, cells were loaded with di-8-
aminonaphthylethenylpyridinium (Di-8-ANNEPS, 5 mM; Molecular Probes)
for 2 min.11 Fluorescent images were acquired by exciting with an Argon
laser at 488 nm. Emission was collected at 560 nm.
In images from Di-8-ANNEPS-stained myocytes, we performed quantita-
tive analysis of T-tubular (TT) architecture using theAuto TT analysis program,
kindly provided by Dr Long-Sheng Song, Iowa University.12
2.5 Calcium transient and cell shortening
measurement
Myocytes were loaded with 10 mM fura-2-acetoxymethyl ester during
12 min. Fura-2 fluorescence was measured on an inverted microscope
adapted for epifluorescence by an IonOptix hardware. The ratio of the
Fura-2 fluorescence (510 nm) obtained after exciting the dye at 340 and
380 nm was taken as an index of Ca2+i .
9
The amplitude of the Ca2+ transient and the integral of the Na+/Ca2+
exchanger (NCX) inwardcurrent induced by rapid application of 15 mM caf-
feine were used to estimate sarcoplasmic reticulum (SR) Ca2+ content.9,13
The NCX current was measured with an Axoclamp 2A amplifier using the
whole-cell voltage-clamp technique. Pipette solution contained (in mM):
K-aspartate 120, KCl 20, Na2ATP 4, MgCl2 4, HEPES 10, glucose 10, and
GTP 0.1; titrated to pH 7.2. All experiments were performed at 308C
using IS or HS supplemented with 0.1 mM ClBa. To ensure that the SR
was consistently loaded with Ca2+, caffeine-dependent currents we mea-
sured after a 1-min rest at a holding potential of 280 mV.
2.6 Detection of spontaneous Ca21 release
by confocal microscopy
Myocytes were loaded with 10 mM fluo-3-acetoxymethyl ester and
mounted on a Zeiss 410 inverted confocal microscope (LSM Tech). Cells
were imaged in a linescan mode along their long axis, exciting with the
488 nm line of an argon laser and collecting emission at .515 nm.9 Data
were analysed using the ‘Sparkmaster’ plugin for ImageJ.14
2.7 Inmunodetection by western blot analysis
Samples of isolated myocytes with a 70+10% yield of viable cells were sub-
jected to control isotonic or hypotonic protocols in the presence orabsence
of 10 mM of the guanylate cyclase inhibitor, ODQ, or 1 mM of the PKG in-
hibitor, KT5823. Twenty minutes after treatment with IS/IS or IS/HS, myo-
cytes were collected and lysed with ice-cold lysis buffer for 30 min.
Proteins from myocyte suspensions were measured by the Bradford
method using BSA as standard. Lysates (90 mg of total protein per gel
line) were seeded in a 10% SDS polyacrylamide gel and transferred to poly-
vinylidene difluoride membranes. Blots were probed overnight with anti-
bodies raised against phospho-Ser2808-RyR2 (Badrilla, Leeds, UK) and
anti-GAPDH (Millipore,Billerica, MA, USA) for normalization. Immunoreac-
tivity was visualized by a peroxidase-based chemiluminescence detection kit
(AmershamBiosciences) using a Chemidoc Imaging System. The signal inten-
sity of the bands in the immunoblots was quantified by densitometry using
the ImageJ software (NIH).
2.8 Statistical analysis
Unpaired Student’s t-test and one-way ANOVA followed by the Tukey–
Cramer or Student–Newman–Keuls post hoc tests were used for statistical
comparisons when appropriate. Data are expressed as means+ SEM.
Differences were considered significant at P ≤ 0.05.
3. Results
3.1 Hypotonic swelling promotes NO
release in isolated ventricular rat myocytes
The effect of switching superfusion from an IS to a HS on cell width and
DAF-FM fluorescence is depicted in Figure 1. Figure 1A shows typical
images indicating that after 20 min superfusion with HS cells maintain
a well-organized sarcomere structure. Brightfield images also indicate
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that HS noticeably enhances cell width. In contrast, cell length was not
significantly enhanced, indicating that HS produces significant cell swel-
ling without axial stretch. Control experiments show that maintaining
cells in IS for an equivalent time frame does not affect cell width. Consist-
ent with other reports,10 there was no evidence of regulatory volume
decrease (RVD) throughout the duration of the experiment. Figure 1B
depicts typical images of a myocyte loaded with DAF-FM, showing
that the NO-sensitivefluorescence increaseswhen the cell is superfused
with HS. The overall results show that, in myocytes stimulated at 0.5 Hz,
changing superfusion from IS to HS induces a gradual increase in
Figure1 Effect of hypotonic superfusion on cell width and DAF-FM fluorescence in rat ventricular myocytes. (A) Representative brightfield images show
amyocyte in IS and 20 minafter superfusionwithHS.Overall resultsbelowshowthat superfusionwithHS induceda significant increase in cellwidth (n ¼ 27
cells from 20 hearts) and had no effect on cell length (n ¼ 24 cells from 19 hearts) compared with cells maintained in IS (n ¼ 11 cells from 8 hearts). (B)
Representative fluorescence images and overall results (n ¼ 35 cells from 24 hearts) showing a gradual increase in DAF-FM fluorescence that becomes
significant 15 min after superfusion with a HS. Arrows indicate where superfusion is changed from IS to HS or maintained in IS to serve as control.
Results are expressed as mean+ SEM; *P, 0.05 vs. cells in IS.
L.A. Gonano et al.458
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DAF-FM fluorescence which becomes significant after 15 min, reaching
a plateau after 20 min. Similar results were obtained when DAF-FM
fluorescence was monitored in quiescent myocytes (not shown).
These results indicate that hypotonic swelling promotes NO release
in adult rat cardiomyocytes. Interestingly, the time course of the in-
crease in cell width is faster than that of DAF-FM fluorescence, being
the time to half-maximum effect 4.42+0.39 min for the change in cell
width and 6.96+0.67 min for DAF-FM fluorescence.
To identify the source of NO production, myocytes were super-
fused with HS in the absence or in the continued presence of
2.5 mM of the non-selective NOS inhibitor, L-NAME, 240 nM of
the NOS1 selective inhibitor, nitroguanidine (NTG), or 1 mM of the
PI3K inhibitor, Wortmannin, which has been shown to inhibit Ca2+-
independent NOS3 activation.7 Figure 2A shows that HS in the
presence of these inhibitors produced a similar degree of cell swelling
compared with HS alone. However, L-NAME and NTG completely
inhibit a HS-induced increase in DAF-FM fluorescence. In contrast,
Wortmannin fails to prevent NO release (Figure 2B). These results
suggest that NOS1 is the source of swelling-induced NO release in
cardiomyocytes. To confirm this, DAF-FM fluorescence was moni-
tored in cells pretreated with Ryanodine (RY) plus cyclopiazonic
acid (CPA), condition that has been shown to inhibit SR function
and the therein located NOS1.15 Figure 2C depicts overall results,
showing that HS fails to increase DAF-FM fluorescence in the
absence of a functional SR. To further confirm the involvement of
NOS1, by a non-pharmacological approach, we measured DAF-FM
fluorescence in myocytes isolated from NOS1 knockout (KO) mice
and in their wild-type (WT) controls. Figure 2D shows that superfusion
with HS produced a significant increase in DAF-FM fluorescence in
WT mice myocytes, and that this increase was significantly reduced
in NOS1KO myoyctes. Although not attaining statistical significance,
NOS1KO myocytes treated with HS showed a tendency to have
higher DAF-FM fluorescence compared with NOS1KO myocytes
treated with IS. These results suggest that NOS1 is the main source for
NO production under hypotonic swelling. However, a minor contribution
by other NOS isoforms could be expected.
3.2 Cytoskeleton integrity is required for
hypotonic swelling-induced NO release
Given the deformation of cell structure promoted by osmotic water
intake, we studied the impact of HS superfusion on cell membrane
and TT architecture. Figure 3A shows typical fluorescence images and
average results obtained in cells labelled with the lipophilic dye
Figure2 Effect of pharmacological inhibition and genetic deletion of NOS1 on cell width and DAF-FM fluorescence in ventricular myocytes subjected to
hypotonic swelling. (A andB) Overall results showing the effect of hypotonic superfusion, either in the absence or presence of NOS inhibitors, on cell width
and DAF-FM fluorescence. L-NAME (n ¼ 12 cells from 7 hearts), Wortmannin (WORT; n ¼ 16 from 7 hearts), and NTG (n ¼ 6 from 4 hearts) did not
significantly affect the degree of cell swelling. However, whereas cells treated with WORT showed a significant increase in DAF-FM fluorescence similar to
the one observed in cells treated with HS alone, cells treated with L-NAME or NTG showed no change in fluorescence when superfused with HS. Results
are expressed as mean+ SEM; *P, 0.05 vs. cells in IS. Arrows indicate where superfusion is changed from IS to HS (except in cells maintained in IS). (C)
Overall results showing that inhibiting SR function with Ryanodine (Ry) plus CPA prevents the increase in DAF-FM fluorescence induced by superfusion
with HS (n ¼ 11 cell from 6 hearts). Arrow indicates where superfusion is changed from IS to HS (except in cells maintained in IS). Results are expressed as
mean+ SEM; *P, 0.05 vs. cells in IS. (D) Overall results showing that superfusion with HS significantly increases DAF-FM fluorescence in WT mice myo-
cytes (n ¼ 4 IS and n ¼ 8 HS from 3 hearts). Whereas this increase is reduced in myocytes from NOS1 KO mice (n ¼ 4 IS and n ¼ 12 HS from 3 hearts).
Arrow indicateswhere superfusion is changed from IS to HS (except in cells maintained in IS). Results are expressed as mean+ SEM; *P, 0.05 vs. cells in IS.
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Di-8-ANNEPS. After processing these images with a software specific-
ally designed to evaluate TT architecture (Auto TT, University of
Iowa),12 we found that superfusion with HS produced a small non-
significant increase in TT spacing and no change in TT integrity index
[transversal elements (TEs) density multiplied by TE regularity], indicat-
ing that, under our experimental conditions, cells maintain sarcolemmal
and TT integrity. Although these results suggest that there is no detubu-
lation with HS, the increase in cell volume should still promote deform-
ationof themicrotubularnetwork,which isknownto transmitmechanical
cues from cell surface to TT–SRcomplex.16 The potential involvement of
microtubules in the mechanotransduction of swelling-induced cell de-
formation to activation of NOS1 was assessed using myocytes preincu-
bated for 2 h with 10 mM colchicine, a manoeuvre known to inhibit
microtubule polymerization.16 Figure 3B shows overall results of cell
width and DAF-FM fluorescence, indicating that inhibiting microtubule
polymerization does not affect the degree of cell swelling, but prevents
a HS-induced increase in NO-sensitive DAF-FM fluorescence. These
results suggest that microtubule integrity is required for HS-induced
NOS1 activation.
3.3 Preventing NO release exacerbates
the hypotonic swelling-induced negative
inotropic effect
Hypotonic swelling has been well established to produce a negative ino-
tropic effect in adult cardiomyocytes.17,18 However, the underlying
mechanisms are not completely understood. Given that NO has been
extensively shown to modulate cardiac contractility,19 we investigated
whether NO release during hypotonic swelling impacts on myocyte
contractility.
Superfusing myocytes with HS produces a slow developing negative
inotropic effect that reaches its maximum after 15 min and then
starts to recover returning to control contractility after 25 min in HS
(see Supplementary material online, Figure S1). Figure 4A shows repre-
sentative traces of twitch contractions and the associated Ca2+ transi-
ents of a cardiomyocyte stimulated to contract at 0.5 Hz under
isotonic conditions and 15 min after switching to HS. Superfusing cells
with HS produced a negative inotropic effect associated with a parallel
decrease in the Ca2+ transient. When experiments were performed
Figure3 Role of membrane TT system and cytoskeleton in hypotonic swelling-induced signal transduction. (A) Representative images and overall results
showing the effect of hypotonic superfusion on cell membrane and TT system integrity. After 20 min in either IS or HS, ventricular myocytes were loaded
with the voltage-sensitive indicator Di-8-ANNEPS. T-tubules are identified as TEs. Cells treated with HS maintain sarcolemmal and TT integrity (n ¼ 21
cells from 7 hearts). (B) Overall data showing that disrupting the microtubular network with colchicine (COLCH) does not affect cell swelling, but prevents
HS-induced increase in DAF-FM fluorescence (n ¼ 11 from 5 hearts). Arrows indicate superfusion change from IS to HS (except in cells maintained in IS).
Results are expressed as mean+ SEM; *P, 0.05 vs. cells in IS.
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Figure 4 Inhibiting NO production exacerbates hypotonic swelling-induced negative inotropic via a cGMP-dependent mechanism. (A) Typical tracings
and overall results of cell length and Ca2+i showing that HS reduces contraction amplitude and the associated Ca
2+ transient (n ¼ 16 from 14 hearts), and
that this effect is significantlyenhancedbyboth L-NAME (n ¼ 9 from5hearts) andNTG(n ¼ 11 from7hearts).Overall dataat15 min inHS,HS + L-NAME,
or HS + NTG (expressed as the percentof the value in IS, IS + L-NAME, and IS + NTG, respectively). Results areexpressed as mean+ SEM; *P, 0.05 vs.
cells in HS. (B) Typical tracings and overall results of the effect of HS on cell length and Ca2+i in the presence and absence of ODQ. Overall data are values at
15 min superfusion with HS (n ¼ 7 from 6 hearts) or HS + ODQ (n ¼ 8 from 6 hearts), expressed as the percent of the value in IS and IS + ODQ, re-
spectively. Results are expressed as mean+ SEM; *P, 0.05 vs. cells in HS. IS and HS were supplemented with DMSO to control for the vehicle used
in the preparation of IS + ODQ and HS + ODQ, respectively.
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in the continued presence of 2.5 mM L-NAME, the HS-induced reduc-
tion in contractility and Ca2+ transient were significantly exacerbated.
Furthermore, the spontaneous recovery of contractility observed
after 25 min of superfusion with HS was lost in cells treated with
L-NAME (see Supplementary material online, Figure S1). Overall
results show that both L-NAME and 240 nM NTG exacerbate the
HS-induced negative inotropic effect. The addition of L-NAME or
NTG did not affect contraction and Ca2+ transient amplitude in IS
(see Supplementary material online, Figure S2). These results suggest
that NOS1-dependent NO release contributes to sustain cardiomyo-
cyte contractile function during hypotonic swelling.
3.4 cGMP mediates NO-induced contractile
support
To explore the signalling cascade by which NO sustains contractile func-
tion during hypotonic swelling, we performed experiments in the pres-
ence and absence of 10 mM of the guanylate cylcase inhibitor, ODQ.
ODQ did not affect contraction and Ca2+ transient amplitude in IS
(see Supplementary material online, Figure S2) nor the degree of cell
swelling (see Supplementary material online, Figure S3A). In contrast,
as shown in the typical tracings and overall data depicted in Figure 4B,
ODQexacerbates theHS-inducednegative inotropiceffect. Interesting-
ly, ODQ enhances the HS-induced negative inotropic effect in a similar
degree than L-NAME and NTG (Figure 4A and see Supplementary mater-
ial online, Figure S4), confirming not only that NOS1 is the source of NO,
but also that, in the setting of hypotonic swelling, the effect of NO on
myocyte contraction is mediated by the cGMP signalling and not by
cGMP-independent mechanisms.
3.5 Mechanisms underlying cGMP-induced
contractile support
To examine whether NO/cGMP-induced contractile support was due
to alterations in SR Ca2+ handling, we measured SR Ca2+ content and
RyR2 Ca2+ release.
Figure 5A depicts typical tracings of Fura-2 fluorescence, showing the
effect of hypotonic superfusion in the absence and presence of NTG on
caffeine-induced SR Ca2+ release. Consistent with other reports,17
superfusion with HS was associated with a small but not significant
reduction in amplitude of the caffeine-induced Ca2+ transient, suggest-
ing that hypotonic swelling does not largely affect SR Ca2+ content.
Supplementary material online, Figure S3B further shows that the
caffeine-induced Ca2+ transient was also not significantly affected by
ODQ. Hypotonic swelling dilutes intracellular content, reducing cyto-
solic Ca2+ buffering. Under these conditions, a larger Fura-2 transient
would be expected when Ca2+ is released into a less buffered compart-
ment, masking a possible reduction in the caffeine-induced Ca2+ transi-
ent. To resolve this issue, we used the integral of the caffeine-induced
NCX current (INCX) as a non-fluorescent readout of SR Ca
2+
content.13 Figure 5B shows that superfusion with HS or HS in the pres-
ence of ODQ did not affect the caffeine-induced INCX compared with
IS, confirming that neither the hypotonic swelling-induced negative ino-
tropic effect nor contractile support provided by the NO/cGMP axis is
determined by alterations in SR-Ca2+ content.
We next examined the impact of HS-derived NO on SR-Ca2+ release
by monitoring Ca2+ spark and wave dynamics as indicators of RyR2 func-
tion. Supplementary material online, Figure S5 shows that superfusing
cells with HS produces a significant decrease in Ca2+ spark frequency.
Although not attaining statistical significance, spark frequency showed
Figure 5 SR Ca2+ content assessed under IS and HS conditions. (A) Typical tracings and overall results of caffeine pulses performed in rat myocytes
superfused for 15 min in IS (n ¼ 5 from 4 hearts), IS + NTG (n ¼ 7 from 4 hearts), HS (n ¼ 8 from 4 hearts), or HS + NTG (n ¼ 12 from 4 hearts).
Neither HS nor HS + NTG significantly affected the amplitude of the caffeine-induced Ca2+ transient. Results are expressed as mean+ SEM. (B)
Typical traces of caffeine-induced NCX inward current under IS and HS superfusion in the presence and absence of ODQ. Overall data of the integrated
NCX current normalized by cell capacitance show the failure of HS and ODQ to affect SR Ca2+ content. IS and HS were supplemented with DMSO
to control for the vehicle used in the preparation of IS + ODQ and HS + ODQ.
L.A. Gonano et al.462
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a tendency to be further reduced in the presence of ODQ. The failure to
observe a significant effect of ODQ on Ca2+ spark frequency could be
due to the fact that as swellingper sedecreases spark frequency, a further
decrease in the presence of ODQ could be difficult to detect. Thus, we
evaluated the velocity of Ca2+wave propagation in cardiomyocytes as a
measure of RyR2 opening properties in response to cytosolic Ca2+.20
Figure 6A depicts typical linescan images of Ca2+ wave propagation in
myocytes superfused for 20 min in HS either in the absence or presence
of 10 mM ODQ, showing that ODQ reduces Ca2+ wave velocity in HS.
Overall results show that whereas ODQ does not affect wave velocity
Figure 6 cGMP increases wave propagation velocity and promotes phosphorylation of RyR2 site Ser2808. (A) Typical example of a linescan image with
the slopes of theCa2+wave fronts from cells inHS in the absence and presenceofODQhighlighted byawhite line. Thegraphon the right depicts theoverall
results of these experiments. Values in HS represent mean data at 15 min superfusion with HS. Results are expressed as mean+ SEM; *P, 0.05 vs. cells in
HS alone. Control solutions were supplemented with DMSO to account for the vehicle used in ODQ solutions. (B) Representative blots and overall results
showing HS increases RyR2 Ser2808 phosphorylation, and that both ODQ and KT5823 prevent this increase. Data are expressed as means+ SEM from
seven independent experiments from six hearts. *P, 0.05 vs. all groups.
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in IS,HSproducesa significant increase inwavevelocity,which isprevented
byODQ.These results suggest thatNOcould be sensitizingRyR2 tocyto-
solic Ca2+ during hypotonic swelling.
To determine how cGMP may be affecting RyR2 function, we
examined the effect of HS on the phosphorylation status of the PKA/
PKG-dependent RyR2 residue, Ser2808. Interestingly, Figure 6B shows
that HS significantly increases Ser2808 phosphorylation, and that this in-
crease ispreventedby both10 mMODQand 1 mMof thePKG inhibitor,
KT5823. To examine whether PKG-dependent phosphorylations are
involved in the inotropic support induced by NO, we evaluated the
effect of HS on contraction amplitude in the presence of KT5823. Sup-
plementary material online, Figure S6 shows that similar to L-NAME,
NTG, and ODQ, inhibiting PKG exacerbates the hypotonic swelling-
induced negative inotropic effect.
4. Discussion
The present study demonstrates, for the first time, that cell swelling
promotes NO release in ventricular cardiomyocytes. Our results also
suggest that NOS1 would be the primary NOS isoform responsible
for NO release, being microtubule integrity required for the mechano-
transduction of swelling-induced NO release. Furthermore, our results
suggest that NO plays a functional role by reducing the hypotonic
swelling-induced negative inotropic effect. We propose that NO via
cGMP/PKG signalling enhances ryanodine receptor sensitivity to
trigger Ca2+, which could contribute to sustain contractile function
during hypotonic swelling.
4.1 Hypotonic swelling promotes NO
production in rat ventricular
cardiomyocytes
Recent reports in tissues other than cardiac have shown evidence, indi-
cating that cell swelling can promote NO release.7,8 Moreover, we have
previously reported that cardiomyocyte axial stretch promotes NO
release.6 However, cardiomyocyte swelling dilutes intracellular con-
tents and deforms the surface membrane without significant changes
in cell length. Thus, extrapolating our results from a myocyte stretch
model to one of cell swelling is not straightforward.
Here, we show that superfusion of cardiomyocytes with a HS, similar
to other reports,10 increases cell width, indicativeof hypotonic cell swel-
ling. This cellular swelling is associated with an increase in the fluores-
cence of the NO sensor, DAF-FM, which was not observed when
cells were superfused with IS. In addition, whereas NOS inhibition pre-
vented the HS-induced increase in DAF-FM fluorescence, it did not
prevent cell swelling, confirming that NO production is due to the acti-
vation of NOS.
There are three known isoforms of NOS within the myocardium,
NOS1, NOS2, and NOS3; of which NOS1 and NOS3 are constitutively
expressed.5 Inducible NOS or NOS2 is mainly expressed during inflam-
matory processes.21 To determine which NOS isoform is involved in
hypotonic swelling-induced NO release, we used (i) the NOS1-specific
inhibitor, NTG and (ii) the PI3K inhibitor, Wortmannin, to inhibit NOS3.
This inhibitor was used taking into consideration that cardiomyocyte
swelling is associated with a reduction in the Ca2+ transient,17,18 and
that recent reports indicate that activation of the PI3/AKT axis can
alter the Ca2+ sensitivity of NOS3 enabling NO production without a
significant rise in [Ca2+]i.
22 Both inhibitors failed to significantly affect
the degree of cell swelling. However, whereas Wortmannin did not
significantly affect HS-induced NO release, NTG completely prevented
the increase in DAF-FM fluorescence. It is important to note that the
fact that none of the inhibitors used, affected the degree of cell swelling,
excludes the possibility that the failure toobservean increase in DAF-FM
fluorescence was due to a reduction in cell swelling. Taken together,
these results suggest that NOS1 is the main enzyme involved in hypoton-
ic swelling-induced NO release. Nevertheless, these findings are at odds
with a recent report indicating that, in endothelial cells, hypotonic
swelling-induced NO production is mediated by Ca2+-independent ac-
tivation of NOS3.7 To validate our observation, we used two additional
approaches: (i) given that NOS1 activation requires a functional SR, we
treated myocytes with the RyR2 inhibitor, ryanodine (Ry), plus the SR
Ca2+ pump (SERCA2A) inhibitor, CPA, an intervention known to
abolish SR function. (ii) We performed experiments in myocytes from
NOS1 knockout mice and their WT controls. Confirming the critical
role played by NOS1, we found that HS-induced NO production was
prevented in the presence of Ry + CPA and significantly reduced in
myocytes from NOS1 knockout mice (Figure 2C and D). Interestingly,
the failure to observe an increase in NO production in myocytes
treatedwithRy + CPAfurther suggests that theNOS1 isoform involved
is the one localized at the SR and not the recently described mitochon-
drial NOS1.15 Further insights into the mechanism underlying NOS1
activation are provided by the results showing that the inhibition of
microtubule polymerization was able to prevent NO release, suggesting
that microtubule integrity is required for hypotonic swelling NOS1
activation (Figure 3B). Although the mechanism by which the cytoskeleton
may promote NOS1 activation is not clear, given the close proximity of
microtubules with the SR (1028 m)16 it could be proposed that microtu-
bules could intervene in the physical transmission of stress or strain from
the sarcolemma to the SR resulting in NOS1 activation. Supporting this
contention, various components of the cytoskeleton network have
been shown to modulate NOS activity and NO production.23
4.2 Impact of hypotonic swelling-induced
NO release on contractile function
Osmotic swelling has been shown to reduce cardiomyocyte contractil-
ity, attributed mainly to a reduction in the Ca2+ transient.17,18 Brette
et al.17 showed that the slow reduction in the Ca2+ transient induced
by HS was mediated by a reduction in L-type calcium current and a de-
crease in SR Ca2+ release in the absence of changes in SR Ca2+ content.
Consistently, our results show that HS produces a slow developing re-
duction in contractility associated with a reduction in the Ca2+ transient
(Figure 4). Interestingly we also show that, after reaching its maximal
negative inotropic effect, contractility and Ca2+ transient, in the contin-
ued presence of HS, start to recover in spite of the lack of RVD (see Sup-
plementary material online, Figure S1).
Given that NO has been shown to have varied effects on cardiac ECC,
determinedat least in part bydifferent subcellular compartmentalization
of NOS isoforms,24 we examined whether hypotonic swelling-induced
NO release had a functional impact on the negative inotropic effect
observed during this process. Here,we show that inhibiting NO produc-
tion enhances the HS-induced negative inotropic effect and prevents the
contractile recovery observed when cells are maintained in HS for
extended periods of time (see Supplementary material online, Figure
S2). Although our results do not shed mechanistic insights into the
mechanism that determine the hypotonic swelling-induced negative ino-
tropic effect, the results presented here suggest that NOS1-derived NO
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provides a mechanism of contractile support that prevents an even
greater impact of cell swelling on cardiac contractile function.
It is now well established that NO may modulate cardiac ECC both
through cGMP-dependent and cGMP-independent mechanisms.25
Our results, showing that guanylate cyclase inhibition mimics the
effect of inhibiting NOS, demonstrates that cGMP-dependent mechan-
isms mediate NO-dependent contractile support and contractile recov-
ery observed during hypotonic swelling.
Consistent with other reports,17 under our experimental conditions,
hypotonic swelling-induced negative inotropic effect was associated
with a small, not significant, reduction in the caffeine-induced Ca2+ tran-
sient (Figure 4B). However, given the non-linear relationship between
ratio and calcium, this does not necessarily mean that SR Ca2+
content was unaltered. Moreover, due to a possible swelling-induced
reduction in Ca2+ buffering, which would alter free cytosolic Ca2+
levels and thus Fura-2 fluorescence ratio, the possibility of a reduction
in SR Ca2+ content contributing to the hypotonic swelling-induced
negative inotropic effect cannot be excluded by this approach. Thus,
to more precisely address SR Ca2+ content, we used the integral of
the caffeine-induced NCX current as a reliable index of SR Ca2+
load.13 These experiments confirmed that hypotonic swelling was not
associated with a significant reduction in SR Ca2+ content.
To verify whether, NO-induced contractile support was due, at least
in part, to a cGMP-dependent stimulatory effect on RyR2 Ca2+ release,
we monitored Ca2+ spark dynamics under IS and HS conditions in the
absence and presence of ODQ. Although we made the interesting,
and until now undescribed, observation that hypotonic swelling, in
itself, reduces Ca2+ spark frequency, we were unable to detect a signifi-
cant further decrease in Ca2+ spark frequency in the presence of ODQ
(see Supplementary material online, Figure S3). However, we found that,
during hypotonic swelling, when Ca2+ waves appear, their propagation
velocity is significantly enhanced compared with the isotonic condition
and that this increase is prevented by ODQ (Figure 6A). Ca2+ waves
represent SR Ca2+ release triggered by cytosolic Ca2+ released from
neighbouring RyR2 clusters. Therefore, the velocity of Ca2+ waves can
be used as an index of RyR2 opening properties during Ca2+ release trig-
gered by cytosolic Ca2+.21 Thus, these results suggest that NO through a
cGMP-dependent mechanism could be sensitizing the RyR2, favouring SR
Ca2+ release for a given Ca2+ trigger. Given that ODQ did not affect SR
Ca2+ content (see Supplementary material online, Figure S3), it seems
unlikely that the observed reduction in Ca2+ wave velocity is determined
by an ODQ-dependent reduction in SR Ca2+ load. The possibility that
NO/cGMP acts at the level of the Ca2+ trigger for Ca2+ release, namely
the L-type Ca2+ current, also seems unlikely based on a recent report,
showing that hypotonic swelling does not affect this current via a
cGMP-dependent mechanism.26 Thus, in the context of cell swelling, an
increase in RyR2 sensitivity could help to sustain SR Ca2+ release in
spite of the well-described reduction in L-type Ca2+ current17,18,26 and
hence contribute to sustain the Ca2+ transient and contractile function.
It is noteworthy that an increase in RyR2 open probability as the only
mechanism responsible for a positive inotropic effect is presently under
debate.27 Although our results suggest that RyR2 sensitization could
have a causal role in the inotropic support provided by NO, we cannot
exclude that NO could also have additional targets that could contribute
to sustain contractile function during hypotonic swelling.
Phosphorylation of RyR2 at site Ser2808 has been shown to increase
the velocity of wave propagation.28 Interestingly, this site is classically
considered to be phosphorylated by PKA. However, in vitro experiments
suggest that Ser2808 can also be phosphorylated by PKG.29 Our results
show that RyR2 Ser2808 phosphorylation is increased by hypotonic
swelling and that this increase is prevented by inhibiting cGMP
(Figure 6B), suggesting that NO/cGMP-dependent phosphorylation of
this site could be responsible for sensitizing the RyR2 to cytosolic
Ca2+ during hypotonic swelling. cGMP-dependent phosphorylation of
Ser 2808 could be mediated by direct activation of PKG or by PKA,
given that cGMP has also been shown to inhibit phosphodiesterases
(PDEs) increasing cAMP availability and thus activating PKA.30 Import-
antly, our results using the specific PKG inhibitor, KT5823, show that
PKG phosphorylates RyR2 Ser2808, demonstrating, for the first time,
the PKG-dependent phosphorylation of this site in a cardiac cellular
model. Our results showing that KT5823, similar to L-NAME, NTG,
and ODQ exacerbate the HS-induced negative inotropic effect (see
Supplementary material online, Figure S4) indicate that NO provides
contractile support, in the context of hypotonic swelling, via a cGMP/
PKG-dependent mechanism. Interestingly, the late contractile recovery
observedwith prolonged HSsuperfusion was also prevented byKT5823
treatment, suggesting that this recovery is also mediated by cGMP/
PKG-dependent mechanisms. However, we cannot exclude that other
PKG-dependent mechanisms aside from the one described here (en-
hancement of RyR2 Ca2+ sensitivity) could be involved in this recovery.
In summary, our results show for the first time that hypotonic swelling
promotes NOS1-dependent NO release in cardiomyocytes. This NO
could have multiple consequences regulating distinct cellular functions
through both cGMP-dependent and independent mechanisms. High-
lighting the physiopathological relevance of the NO release we des-
cribed herein, we show its impact on swelling-induced contractile
dysfunction, where it provides inotropic support by a cGMP/PKG-de-
pendent mechanism. This mechanism may help to sustain contractile
function in different pathological situations associated with cell swelling.
4.3 Limitations
In this study, we provide evidence showing that hypotonic swelling pro-
motes NOS1-dependent NO release. Our results using colchicine to
disrupt microtubules further suggest that the microtubular network
may be involved in the mechanotranduction of cell swelling to NOS1
activation. However, the observation of a lag between cell swelling
and NO production could suggest that other mechanisms, in addition
to mechanical forces, could be involved. Nevertheless, this interpre-
tetation of a more complex scenario could arise from a limitation in
NO detection. Indeed, the observed lag could be due a lower sensitivity
for NO detection compared with that for cell width detection. Thus, it
could be conceivable that NO production could have a rather similar
time course to that of changes in cell width, but is not detected until it
builds up inside the cell reaching the threshold for detection. Clearly,
these issues indicate that exploring the mechanisms involved in the
mechanotransduction of NO release during hypotonic swelling
deserves further study.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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